BioXcel Therapeutics Announces Reverse Stock Split
BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it will effect a 1-for-16 reverse stock split of its common stock.
(RTTNews) - BioXcel Therapeutics, Inc. (BTAI), Thursday announced a reverse stock split of 1-for-16 to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq ...
Most Wall Street analysts expect shares of Nvidia and Lam Research to soar in 2025. Nvidia's leadership in artificial ...
Honeywell said it will split into three companies. The aerospace giant said it will separate its aerospace, automation and ...
Al-Baha Investment and Development Co.said its post-reverse stock split share capital will be 218.30 million, instead of 2.18 ...
Netflix ( NFLX 0.22%) has shown investors once again who's on top of the streaming industry. On Jan. 21, the company reported ...
Tonix Pharmaceuticals (TNXP) stock plunged after the company carried out a 1-for-100 reverse stock split as it awaits approval for its ...
Info Edge shares currently carry a face value of ₹10 each and this will be the first instance of the company dividing its stock.
AKI India has provided exceptional long-term returns, with shares multiplying sixfold due to a 3:10 bonus issue and a 1:5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback